Leptin receptor-mediated regulation of cholinergic neurotransmitter phenotype in cells of central nervous system origin.
Leptin is an adipocyte-secreted hormone that regulates body weight and exerts effects on hematopoiesis, reproduction, and immunity. The leptin receptor (OBR) shares sequence similarity and signaling capabilities with receptors for cytokines of the ciliary neurotrophic factor (CNTF) family. Our previous finding that CNTF and leptin exert similar anti-obesity effects and activate common neuronal signaling pathways, prompted us to investigate whether leptin may share with CNTF the ability to regulate the expression of specific neuronal genes. To this end, we established a cell line, derived from the murine septal cholinergic neuronal cell line SN-56, which stably expresses OBR. In this cell line, termed SN-56/OBR, leptin induces STAT transcription factor activation and STAT-dependent reporter gene expression in a manner similar to that of CNTF. Furthermore, in SN-56/OBR cells both CNTF and leptin produce changes in neurotransmitter and neuropeptide phenotype characteristic of cholinergic neurons, such as an increase in choline acetyltransferase and vasoactive intestinal polypeptide, and a decrease in neuropeptide Y expression. SN-56/OBR cells thus constitute an interesting new model system to investigate leptin action in cells of central nervous system origin. Possible physiological implications of OBR's intrinsic ability to regulate cholinergic phenotypic markers are discussed.
Di Marco
A
A
Istituto di Ricerche di Biologia Molecolare P. Angeletti (IRBM), Pomezia, Italy.
Demartis
A
A
Gloaguen
I
I
Lazzaro
D
D
Delmastro
P
P
Ciliberto
G
G
Laufer
R
R
D017398:Alternative Splicing; D000818:Animals; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D002460:Cell Line; D002795:Choline O-Acetyltransferase / Q000096:biosynthesis; D020934:Ciliary Neurotrophic Factor / Q000378:metabolism; D016207:Cytokines / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation; D005786:Gene Expression Regulation; D017930:Genes, Reporter; D020738:Leptin / Q000378:metabolism; D051379:Mice; D009474:Neurons / Q000378:metabolism; D009478:Neuropeptide Y / Q000096:biosynthesis; D018377:Neurotransmitter Agents / Q000096:biosynthesis*; D010641:Phenotype; D012313:RNA / Q000378:metabolism; D020801:Receptor, Ciliary Neurotrophic Factor / Q000235:genetics / Q000378:metabolism; D011956:Receptors, Cell Surface; D011950:Receptors, Cholinergic / Q000378:metabolism*; D054411:Receptors, Leptin; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015534:Trans-Activators / Q000378:metabolism; D014660:Vasoactive Intestinal Peptide / Q000096:biosynthesis
D002352:Carrier Proteins; D020934:Ciliary Neurotrophic Factor; D016207:Cytokines; D020738:Leptin; D009478:Neuropeptide Y; D018377:Neurotransmitter Agents; D020801:Receptor, Ciliary Neurotrophic Factor; D011956:Receptors, Cell Surface; D011950:Receptors, Cholinergic; D054411:Receptors, Leptin; D015534:Trans-Activators; C515447:leptin receptor, mouse; D014660:Vasoactive Intestinal Peptide; D012313:RNA; D002795:Choline O-Acetyltransferase